FDA Authorizes First Non-Prescription Home Coronavirus Test

FDA Authorizes First Non-Prescription Home Coronavirus Test

The test delivers results to your smartphone within 15 minutes of collecting a sample.

The FDA authorized the first coronavirus test that can be bought in a store without a prescription on December 15, says NPR.

The at-home test is made by the Australian company Ellume and will be available in January. It is administered using a swab and produces results within 15 minutes via a smartphone app. Collecting the sample for testing takes about five minutes.

“[The] authorization is a major milestone in diagnostic testing for COVID-19,” FDA Commissioner Stephan Hahn said.

The test will cost about $30 and can be used for both adults and children as young as 2-years-old.

About the Author

Nikki Johnson-Bolden is an Associate Content Editor for Occupational Health & Safety.

Download Center

  • EHS Buyer's Guide

    Download this buyer's guide to make more informed decisions as you're looking for an EHS management software system for your organization.

  • Online Safety Training Buyer's Guide

    Use this handy buyer's guide to learn the basics of selecting online safety training and how to use it at your workplace.

  • COVID Return-to-Work Checklist, Fall 2021

    Use this checklist as an aid to help your organization return to work during the COVID-19 pandemic in a safe and healthy manner.

  • SDS Buyer's Guide

    Learn to make informed decisions while searching for SDS Management Software.

  • Risk Matrix Guide

    Risk matrices come in many different shapes and sizes. Understanding the components of a risk matrix will allow you and your organization to manage risk effectively.

  • Industry Safe

Featured Whitepapers

OH&S Digital Edition

  • OHS Magazine Digital Edition - September 2021

    September 2021


      Managing Combustible Dust and Risk Mitigation
      The Rising Popularity of Safety Helmets on the Jobsite
      Five Tips for a Successful Wear Trial
      Medical Surveillance Versus Medical Screening
    View This Issue